Latest Insider Transactions at Evoke Pharma Inc (EVOK)
This section provides a real-time view of insider transactions for Evoke Pharma Inc (EVOK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evoke Pharma Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evoke Pharma Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
David A Gonyer CEO |
SELL
Open market or private sale
|
Direct |
23,954
-6.59%
|
$47,908
$2.94 P/Share
|
|
Dec 11
2020
|
David A Gonyer CEO |
SELL
Open market or private sale
|
Direct |
48,046
-11.67%
|
$96,092
$2.9 P/Share
|
|
Dec 11
2020
|
Matthew J D'Onofrio Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,357
-12.44%
|
$80,714
$2.91 P/Share
|
|
Dec 10
2020
|
Matthew J D'Onofrio Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,643
-1.71%
|
$11,286
$2.95 P/Share
|
|
Dec 09
2020
|
Matthew J D'Onofrio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,000
+12.23%
|
$0
$0.4 P/Share
|
|
Dec 09
2020
|
David A Gonyer CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
72,000
+14.88%
|
$0
$0.4 P/Share
|